Caveolin-1 and Flotillin-1 are markers for lipid raft membrane (LRM) and caveolae rich domains, CD-71 marks high density non-lipid raft domains of plasma membranes and Rab-5 marks the early endosomal vesicles containing fractions. (b) Membrane and soluble fractions from MIHA and Hep3B cells were isolated as described in methods section and Western blotted for Agrin. Rho-GDI and Integrin β1 served as markers for soluble and membrane fractions, respectively. (c) Hep3B cells were treated with Agrin antibody and recombinant Alexa 488 labeled cholera toxin B (CTxB) for 1h at 4°C, allowed to internalize at 37°C for the indicated time-points, fixed and processed for immunofluorescence microscopy analysis. Representative confocal images of internalization assay are shown. Boxed areas represent enlarged panels. Scale bar: 10μm. (d) Line scan signal intensity plots for the indicated cells at 4°C (cell-surface) and 37°C (internalized) are shown. Fluorescence signal intensity is represented in arbitrary units. Scale bar: 10μm. (e) Hep3B cells were incubated with Agrin antibody as in (c) and allowed to internalize for indicated time-points. 4% PFA fixed cells were immunostained with rabbit anti-EEA-1 antibody for 1h at room temperature (RT), followed by anti-mouse Alexa 555 and anti-rabbit Alexa 488 secondary antibodies. MHCC-LM3 cells were transfected with either vector control, full length Agrin-GFP, N-terminal Agrin GFP or C-terminal Agrin GFP constructs. 2 days post-transfection, total cell lysates were immunoprecipitated with a GFP monoclonal antibody and Western blotted using D2 or MAb5204 Agrin antibodies. GFP Western blot shows the expression of the constructs. (c) Differentiated mouse muscle C2C12 cells were pre-treated with the indicated antibodies (10μg/ml) for 12h, then either left untreated or treated with soluble Agrin (1μg/ml) for another 12h, immunoprecipitated with MuSK antibody and Western blotted using phospho-tyrosine specific 4G10 monoclonal antibody. The blot was stripped and re-probed for MuSK expression. (d) MHCC-LM3 cells treated with the indicated Agrin antibodies (10μg/ml) for 12h were immunoprecipitated with MuSK antibody and Western blotted using phospho-tyrosine specific 4G10 monoclonal antibody. The blot was stripped and re-probed for MuSK expression.
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